Long-term low-dose cyclosporine therapy for severe psoriasis: Effects on renal function and structure

Journal of the American Academy of Dermatology

Volumn 35, Issue 5 I, 1996, Pages 710-719

  Lowe, Nicholas J ^a,b,e   Wieder, Joshua M ^a,b   Rosenbach, Alan ^a   Johnson, Kent ^c   Kunkel, Robin ^c   Bainbridge, Carol ^d   Bourget, Teresa ^a   Dimov, Ivailo ^a   Simpson, Karen ^a   Glass, Edwin ^b   Grabie, Morris T ^b  

^a Skin Res Foundation of California   (United States)

^b SAINT JOHN'S HEALTH CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Sandoz Pharma Ltd   (Switzerland)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FUNCTION; LONG TERM CARE; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS;

EID: 16144364925     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90726-4     Document Type: Article

References (24)

1. Borel JF. Mechanism of action and rationale for cyclosporin A in psoriasis. Br J Dermatol 1990;122(suppl 36):5-12.
2. Cooper KD, Baadsgaard O, Ellis CN, et al. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis. J Invest Dermatol 1990;94:649-56.
3. Van Joost T, Heule F, Stolz E, et al. Short term use of cyclosporin A in severe psoriasis. Br J Dermatol 1986;114: 615-20.
4. Ellis CN, Gorsulowsky DC, Hamilton TA, et al. Cyclosporine improves psoriasis in a double-blind study. JAMA 1986;256:3110-6.
5. Timonen P, Friend D, Abeywickrama K, et al. Efficacy of low-dose cyclosporine A in psoriasis. Br J Dermatol 1990; 122(suppl 36):33-9.
6. Van Joost T, Bos JD, Heule F, et al. Low-dose cyclosporine A in severe psoriasis: a double-blind study. Br J Dermatol 1988;118:183-90.
7. Ellis CN, Fradin MS, Messana JM, et al. Cyclosporine for plaque-type psoriasis: results of a multi-dose, double-blind trial. N Engl J Med 1991;324:277-84.
8. Mihatsch MJ, Thiel G, Spichtin HP, et al. Morphological findings in kidney transplants after treatment with cyclosporine. Transplant Proc 1983;15(suppl 1):2821-35.
9. Mihatsch MJ, Thiel G, Basler V, et al. Morphological patterns in cyclosporine treated renal transplant recipients. Transplant Proc 1985;17(suppl 1):101-16.
10. Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988;20(suppl 3):759-71.
11. Bos JD, Van Joost T, Powles AV, et al. Use of cyclosporine in psoriasis. Lancet 1989;2:1500-2.
12. Meinardi MMHM, Dene MA, Bos JD. Oral cyclosporine A in the treatment of psoriasis: an overview of studies performed in the Netherlands. Br J Dermatol 1990;122(suppl 36):27-31.
13. Powles AV, Baker BS, Valdimarsson H, et al. Four years of experience with cyclosporine A for psoriasis. Br J Dermatol 1990;122(suppl 36):13-9.
14. Feutren G, Abeywickrama K, Friend D, et al. Renal function and blood pressure in psoriatic patients treated with cyclosporine A. Br J Dermatol 1990;122(suppl 36):57-69.
15. Pei Y, Scholey J, Katz A, et al. Chronic nephrotoxicity in psoriasis patients treated with low-dose cyclosporine. Am J Kidney Dis 1994;23:528-36.
16. Powles AV, Cook T, Hulme B, et al. Renal function and biopsy findings after 5 years' treatment with low dose cyclosporine for psoriasis. Br J Dermatol 1993;128: 159-65.
17. Zachariae H, Hansen H-E, Kragballe K, et al. Morphologic renal changes during cyclosporine treatment of psoriasis. J Am Acad Dermatol 1992;26:415-9.
18. Mihatsch MJ, Belighiti D, Bohman SO, et al. Kidney biopsies in control or cyclosporine A-treated psoriatic patients. International Kidney Biopsy Registry of Cyclosporine A (Sandimmune) in Autoimmune Diseases. Br J Dermatol 1990;122(suppl 36):95-100.
19. Gilbert SC, Emmett M, Menter A, et al. Cyclosporine therapy for psoriasis: serum creatinine measurements are an unreliable predictor of decreased renal function. J Am Acad Dermatol 1989;21:470-4.
20. Mulligan JS, Blue PW, Hasbargen JA. Methods of measuring GFR with Tc-99M DTPA: an analysis of several common methods. J Nucl Med 1990;31:1211-9.
21. Becker JA, Carvlin M, Choyke PL, et al. Clinical urology; vol 3. Philadelphia: WB Saunders, 1990:2597.
22. Rehling MD, Moller ML, Thamdrup B, et al. Simultaneous measurement of renal clearance and plasma clearance of TC-99 M labelled diethylenetriaminepenta-acetate, Cr-51 labelled ethylenediamine tetraacetate and inulin in man. Clin Sci (Calch) 1984;66:613-9.
23. Russel C, Bischoff P, Kontzen F, et al. Measurement of glomerular filtration rate: single injection plasma clearance method without urine collection. J Nucl Med 1985;26: 1243-7.
24. Lowe NJ. Systemic treatment of severe psoriasis: the role of cyclosporine. N Engl J Med 1991;324:333-4.